Concordance, Variance, and Outliers in 4 Contemporary Cardiac Troponin Assays: Implications for Harmonization

作者: Jacobus P J Ungerer , Louise Marquart , Peter K O'Rourke , Urs Wilgen , Carel J Pretorius

DOI: 10.1373/CLINCHEM.2011.175059

关键词:

摘要: BACKGROUND: Data to standardize and harmonize the differences between cardiac troponin assays are needed support their universal status in diagnosis of myocardial infarction. We characterized variation methods, comparability 99th-percentile cutoff thresholds, occurrence outliers 4 assays. METHODS: Cardiac was measured duplicate 2358 patient samples on platforms: Abbott Architect i2000SR, Beckman Coulter Access2, Roche Cobas e601, Siemens ADVIA Centaur XP. RESULTS: The observed total variances 3 I (cTnI) methods cTnI T (cTnT) were larger than expected from analytical imprecision (3.0%–3.7%). between-method variations 26% 127% cTnT dominant contributors variances. misclassification results according 99th percentile 3%–4% 15%–17% cTnT. assay identified 49% more as positive cTnI. Outliers detected 1 (0.06%) with Abbott, 8 (0.45%) Coulter, 10 (0.56%) Roche, (0.17%) Siemens. CONCLUSIONS: definition infarction should not depend choice analyte or analyzer, between- within-method described here need be considered application this respect. that cannot explained by discordant classification respective percentiles addressed.

参考文章(20)
J P Ungerer, M J Ungerer, W J Vermaak, Discordance between measured and calculated total carbon dioxide. Clinical Chemistry. ,vol. 36, pp. 2093- 2096 ,(1990) , 10.1093/CLINCHEM/36.12.2093
J. P. J. Ungerer, C. J. Pretorius, G. Dimeski, P. K. O'Rourke, S. A. Tyack, Falsely elevated troponin I results due to outliers indicate a lack of analytical robustness Annals of Clinical Biochemistry. ,vol. 47, pp. 242- 247 ,(2010) , 10.1258/ACB.2010.010012
Sonia L. La'ulu, William L. Roberts, Performance characteristics of five cardiac Troponin I assays Clinica Chimica Acta. ,vol. 411, pp. 1095- 1101 ,(2010) , 10.1016/J.CCA.2010.04.008
Stefan James, Mats Flodin, Nina Johnston, Bertil Lindahl, Per Venge, The Antibody Configurations of Cardiac Troponin I Assays May Determine Their Clinical Performance Clinical Chemistry. ,vol. 52, pp. 832- 837 ,(2006) , 10.1373/CLINCHEM.2005.064857
Per Venge, Stefan James, Leif Jansson, Bertil Lindahl, Clinical Performance of Two Highly Sensitive Cardiac Troponin I Assays Clinical Chemistry. ,vol. 55, pp. 109- 116 ,(2009) , 10.1373/CLINCHEM.2008.106500
J. Martin Bland, DouglasG. Altman, Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet. ,vol. 327, pp. 307- 310 ,(1986) , 10.1016/S0140-6736(86)90837-8
Mauro Panteghini, A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins. Clinical Chemistry and Laboratory Medicine. ,vol. 47, pp. 1179- 1182 ,(2009) , 10.1515/CCLM.2009.295
Maciej Adamczyk, R Jeffrey Brashear, Phillip G Mattingly, Coprevalence of Autoantibodies to Cardiac Troponin I and T in Normal Blood Donors Clinical Chemistry. ,vol. 56, pp. 676- 677 ,(2010) , 10.1373/CLINCHEM.2009.138099
, David A. Morrow, Christopher P. Cannon, Robert L. Jesse, L. Kristin Newby, Jan Ravkilde, Alan B. Storrow, Alan H.B. Wu, Robert H. Christenson, National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Circulation. ,vol. 115, ,(2007) , 10.1161/CIRCULATIONAHA.107.182882